Sanofi India Q2 Net up 26% to Rs 51.2 crore

NEW DELHI: Drug firm Sanofi India today reported a 26.41 per cent rise in net profit to Rs 51.2 crore for the quarter ended June 30, 2013, mainly on account of robust exports.

The company had posted a net profit of Rs 40.5 crore for the corresponding period previous fiscal, Sanofi India said in a filing to BSE.

Net sales of the company also rose to Rs 410 crore for the quarter under consideration from Rs 374.1 crore for the same period a year ago, it added.

The company's board of directors has declared an interim dividend of Rs 10 per equity share of Rs 10 to those members who qualify as on August 6, 2013, Sanofi India said.

"Better export performance during the quarter and half year ended June 30, 2013, has resulted in the profitability of the company," it added.

Sanofi India provides medicines for several therapeutic areas such as cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and consumer healthcare.

Shares of Sanofi India today closed at Rs 2,375 apiece on BSE, down 1.86 per cent from their previous close.